Jaypirca

2 trends tracked about this subject — the full history, oldest to newest below.

◼ Archived Business

Genmab releases new phase 2 data for its antibody-drug conjugate, prompting claims of superiority over rival treatments.

6 sources 6 articles v 4 34d ago

◼ Archived Business 🔮 fades

The European Medicines Agency has issued a positive opinion recommending the approval of Eli Lilly's Jaypirca for chronic lymphocytic leukemia.

10 sources 14 articles v 11 134d ago